Infectious Disease | COVID-19

QIAreach Anti-SARS-CoV-2 Total Test

Detect SARS-CoV-2 antibodies in just three minutes

QIAGEN is developing the QIAreach Anti-SARSCoV- 2 Total Test, a digital assay to detect total SARS-CoV-2 antibodies (IgA, IgG, IgM), helping you identify possible past infection – even in those who never showed symptoms.

Built on state-of-the-art nanoparticle fluorescence technology, it will let you test up to eight patients simultaneously with true walk-away capability.

Flexible and scalable to meet your needs

Digital and connected

The QIAreach Anti-SARS-CoV-2 Total Test will provide fast testing on a digital portable device for ease of use, reliability and integrated data management without the need for centralized laboratory infrastructure.

Test results are stored on the Anti-CoV2 eStick and displayed on the QIAreach eHub, and the assay can be used with or without connection to a computer for optional data export to LIS.

QIAreach Anti-SARS-CoV-2 Total Test is currently under development and is coming soon.